Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model.
Malignant mesothelioma (MM) is an aggressive, uniformly fatal serosal tumour, usually associated with asbestos exposure, for which there currently is no effective treatment. In order to gain insight into the mechanism(s) whereby MM might escape immune surveillance, a murine model for MM was used (a) to characterise the tumour-infiltrating lymphocytes (TIL) and macrophages (TIM) phenotypically, (b) to examine systemic immune recognition of MM, and (c) to examine the possible influence of tumour-derived cytokines on systemic and local pathobiological manifestations of MM. A profound down-regulation of lymphocyte surface markers, known to be involved in T cell activation, was found in TIL. Likewise, although TIM were present in large numbers, their expression of MHC class II antigen and integrins was weak or absent, suggestive of altered functional activity. Significant amounts of cytokines, in particular transforming growth factor beta, interleukin-6 (IL-6), IL-1 and tumour necrosis factor were produced during the course of MM tumour development-directly by the MM cells and/or indirectly in response to tumour growth. These factors may contribute both to derangement of antitumour effector mechanisms and to the clinical and pathological manifestations of the disease.
Bielefeldt-Ohmann
H
H
University of Western Australia Department of Medicine, QEII Medical Centre, Nedlands.
Fitzpatrick
D R
DR
Marzo
A L
AL
Jarnicki
A G
AG
Himbeck
R P
RP
Davis
M R
MR
Manning
L S
LS
Robinson
B W
BW
D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D016207:Cytokines / Q000096:biosynthesis*; D005260:Female; D016130:Immunophenotyping; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D008264:Macrophages / Q000473:pathology; D008654:Mesothelioma / Q000276:immunology* / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D016212:Transforming Growth Factor beta / Q000502:physiology
D015703:Antigens, CD; D016207:Cytokines; D016212:Transforming Growth Factor beta